Ligand-based design of potent Dipeptidyl Peptidase-IV (DPP-IV) inhibitors in heterocyclic compounds using QSAR, molecular docking, dynamic simulations, ADMET, and pharmacological profiling for anti-diabetic potential
2026In Silico Research in BiomedicineJournalOpen access
10.1016/j.insi.2026.100184Full text0 citations